Schizophrenia; Psychosis research hub
4 indexed studies · 4 currently recruiting
- not yet recruitingPHASE3
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia
This study is looking at how a new medicine, Xanomeline/Trospium (XT), affects thinking and memory in adults with schizophrenia over one year. XT is already approved for treating other symptoms but this study focuses on cognitive benefits.
Austria · Belgium · Czechia - recruitingNA
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
This study looks at how cannabis use affects memory and brain function in people with psychosis and others. Researchers want to see if taking a break from cannabis for 28 days can improve these things, using brain scans to understand the changes.
Canada - recruitingNA
Outcomes From Remediation and Behavioural Intervention Techniques
This study looks at how well different talking therapies, like CBT for psychosis and brain training, work for people with conditions like schizophrenia. Researchers want to find out who benefits most from each therapy, or a combination, to help improve daily life.
Canada - recruitingNA
Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations
This study looks into whether regular `top-up` treatments with a special brain stimulation, called rTMS, can help people with schizophrenia or psychosis who hear voices. We want to see if these extra sessions can make the good effects of the treatment last longer.
France